Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Launched by KENYATTA NATIONAL HOSPITAL · Jun 25, 2025
Trial Information
Current as of July 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new approach called DADA LINK to help more women in Kenya get screened for cervical cancer and receive timely treatment if needed. The goal is to make it easier for women to complete the steps from screening to follow-up care by having care coordinators support clinic staff and use a mobile health platform to keep everything organized. The study will last about a year, with an extra six months to see how well the approach works over time and how much it costs.
Women between the ages of 25 and 49 who are not pregnant, not recently given birth (within six weeks), and do not already have a confirmed diagnosis of cervical cancer may be eligible to participate. If you join, you can expect clinic staff to collect information about your cervical cancer screening and any follow-up care. In some clinics, care coordinators will help ensure that you get the right care and may ask you some questions after your visit to see how the program is working. This study is not yet recruiting participants but aims to improve cervical cancer care in a way that is patient-friendly and effective.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Women ages 25-49 years
- Exclusion Criteria:
- • Pregnant women
- • Women ≤6 weeks postpartum
- • Women already confirmed to have cervical cancer
About Kenyatta National Hospital
Kenyatta National Hospital (KNH) is a premier healthcare institution in Kenya, renowned for its commitment to advancing clinical research and improving patient care. As the largest referral and teaching hospital in the country, KNH plays a pivotal role in the development and implementation of innovative medical treatments and interventions. With a dedicated team of healthcare professionals and researchers, the hospital conducts clinical trials that adhere to rigorous ethical standards and regulatory guidelines, aiming to enhance health outcomes and contribute to the global medical community. Through its collaborative efforts and focus on evidence-based practices, Kenyatta National Hospital is at the forefront of addressing pressing health challenges in Kenya and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nairobi, , Kenya
Patients applied
Trial Officials
Rose J Kosgei, MBChB,MMed,MSc,Fell.GynOnc,PhD
Principal Investigator
University of Nairobi
Leslie Johnson, MPH, MLitt, PhD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported